Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2023-11-21 00:00:00 ET · period of report 2023-11-17 · accession 0001209191-23-056198 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-21 | 2023-11-17 | HRTX | Forbes William P | EVP, Chief Development Off | P - Purchase | $1.09 | +25.0K | 79.0K | +46% | +$27.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-17 | P | A | 25,000 | $1.09 | 79,000 | D | — | — |